Jacobsen Capital Management Abb Vie Inc. Transaction History
Jacobsen Capital Management
- $234 Million
- Q4 2024
A detailed history of Jacobsen Capital Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Jacobsen Capital Management holds 3,254 shares of ABBV stock, worth $629,486. This represents 0.25% of its overall portfolio holdings.
Number of Shares
3,254
Previous 3,148
3.37%
Holding current value
$629,486
Previous $621,000
6.92%
% of portfolio
0.25%
Previous 0.27%
Shares
8 transactions
Others Institutions Holding ABBV
# of Institutions
4,020Shares Held
1.28BCall Options Held
18.3MPut Options Held
13.4M-
Vanguard Group Inc Valley Forge, PA173MShares$33.5 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$15.4 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10 Billion0.75% of portfolio
-
Morgan Stanley New York, NY38.7MShares$7.49 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $342B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...